Celltrion, Top Search Ranking... Stock Price -0.46%
As of 9:30 AM on the 13th, Celltrion is trading at 323,000 KRW, down 0.46% from the previous day. This marks a 17.88% increase compared to June 15. Celltrion is known as a manufacturer of protein and biopharmaceutical products.
Over the past five days, individual investors have net purchased 81,551 shares, while foreigners and institutions have net sold 180,843 shares and net purchased 87,042 shares, respectively.
On July 10, Celltrion became a market topic with the announcement of a "115.6 billion KRW contract for the contract manufacturing of a migraine treatment drug."
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- [Breaking] Central Labor Relations Commission: "Second Post-Mediation Fails for Samsung Electronics"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Looks Even More Like Him in Person": Crowds Gather to See 'Trump Lookalike' Albino Buffalo
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
